MedPath

The Big Breakfast Study

Not Applicable
Completed
Conditions
Weight Loss
Obesity
Interventions
Other: High Fibre
Other: High Protein
Registration Number
NCT03077295
Lead Sponsor
University of Aberdeen
Brief Summary

This weight loss study will investigate the impact of diet composition and meal size (large breakfast meals and smaller evening meals) on body weight, energy balance and eating behaviour, by altering calorie (meal) distribution.

Detailed Description

The aim of this study is to further strengthen our understanding of the role of dietary components (in particular fibre and protein) in a healthy diet. The information gained from this research will lead to better policy advice, particularly in relation to healthy weight management, metabolic control, mental health and intestinal health. It will also lay the foundations to produce healthier primary products and aid the food industry in developing new and healthier products (e.g. products that aid hunger control and satiety). This will be addressed through four interlinked objectives:

O1: Healthy weight management and improved metabolic and mental health O2: Identification of gut bacteria and compounds of relevance to vascular and gut health O3: Linking fibre consumption to intestinal microbial communities and health O4: Mathematical modelling of interactions between diet and gut microbial communities

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
19
Inclusion Criteria
  • BMI ranging from 27-42 kg/m2;
  • those habitually consuming breakfast (at least 5 times a week).
Exclusion Criteria
  • women who are pregnant, planning to be pregnant or breastfeeding
  • subjects with food allergy
  • diagnosis of diabetes, hypertension, renal, hepatic, haematological disease or coronary heart disease
  • having given a pint of blood for transfusion purposes within the last month
  • unsuitable veins for blood sampling
  • inability to understand the participant information sheet
  • inability to speak, read and understand the English language
  • those on any prescription medications (other than oral contraceptives)
  • those on any specific diet regimes
  • those on any weight loss programmes (that may be affecting lifestyle, physical activity and diet).

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
High Fibre to High-Protein (HF-HP)High Fibre* Phase 1: no intervention, habitual diet for 4 days and then 3day maintenance diet * Phase 2: consumption of HF meals for 4 weeks * Phase 3: washout for 1 week, controlled maintenance diet * Phase 4: consumption of HP meals for 4 weeks
High Protein to High-Fibre (HP-HF)High Protein* Phase 1: no intervention, habitual diet for 4 days and then 3day maintenance diet * Phase 2: consumption of HP meals for 4 weeks * Phase 3: washout for 1 week, controlled maintenance diet * Phase 4: consumption of HF meals for 4 weeks
High Protein to High-Fibre (HP-HF)High Fibre* Phase 1: no intervention, habitual diet for 4 days and then 3day maintenance diet * Phase 2: consumption of HP meals for 4 weeks * Phase 3: washout for 1 week, controlled maintenance diet * Phase 4: consumption of HF meals for 4 weeks
High Fibre to High-Protein (HF-HP)High Protein* Phase 1: no intervention, habitual diet for 4 days and then 3day maintenance diet * Phase 2: consumption of HF meals for 4 weeks * Phase 3: washout for 1 week, controlled maintenance diet * Phase 4: consumption of HP meals for 4 weeks
Primary Outcome Measures
NameTimeMethod
Change in Energy Balancemeasured up to day 71 of study

Chronic influence on energy balance (body weight, kg)

Secondary Outcome Measures
NameTimeMethod
Body CompositionBaseline & week 4 of each treatment

Air Displacement Plethysmography (BodPod) to measure body fat as part of the 4 compartment model

Acute effects on biomarkers of health after test mealsBaseline & week 4 of each treatment

blood samples analysed for Glucose, Lipids and Hormones

Faecal sample analysis for gut healthup to 10 weeks

Chronic influence on changes in gut microbiota

Acute effects on appetite after test mealsBaseline & week 4 of each treatment

Appetite questionnaires recorded on Visual Analogue Scales every 30mins on test days

Bone DensityBaseline & week 4 of each treatment

Dual Energy X-ray Absorptiometry (DXA) Scan to measure fat mass, fat free mass \& bone density as part of the 4 compartment model

Acute effects on gastric emptying after test mealsBaseline & week 4 of each treatment

gastric emptying (stable isotope, Octanoic acid labelled breath samples)

Resting Metabolic Rate (RMR) before & after test mealsBaseline & week 4 of each treatment

Chronic influence on metabolism or Thermic Effect of Food (TEF) using indirect calorimetry measurement

Total Body WaterBaseline & week 4 of each treatment

Deuterium Dilution to measure Total Body Water (TBW) as part of the 4 compartment model

Trial Locations

Locations (1)

The Rowett Institute

🇬🇧

Aberdeen, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath